Fidelity Equity Income Fund
FEQIX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Fidelity Equity-Income Fund (FEQIX) is a diversified domestic equity mutual fund managed by Fidelity Investments that seeks reasonable income and considers potential capital appreciation as a secondary objective. The fund normally invests at least 80% of its assets in income-producing equity securities, primarily large-cap value stocks of domestic and foreign issuers; it may also allocate to other equity securities and lower-quality debt securities. It emphasizes dividend-paying companies across sectors such as financials, healthcare, consumer staples, and energy, with a portfolio turnover rate of approximately 19% and net assets exceeding $9 billion. The fund offers share classes including retail (FEQIX), institutional, and advisor versions, available through brokerage platforms and retirement accounts targeting individual investors, financial advisors, and institutions seeking income-oriented equity exposure. Geographically, it focuses primarily on U.S. equities (around 85% allocation), with up to 14% in non-U.S. stocks for diversification. Fidelity Investments, the fund's sponsor, founded Fidelity Management & Research in 1946 and is headquartered in Boston, Massachusetts. Portfolio management is led by Ramona Persaud since October 2011, who also oversees related strategies including Fidelity Global Equity-Income Fund and sub-portfolios in multi-asset income funds. The fund maintains a gross expense ratio of about 0.53% and delivers quarterly dividends, with recent payouts including $0.312 per share in April 2025 and a trailing 12-month yield around 1.64%. In recent developments, the fund has sustained stable management with no major portfolio manager changes or reorganizations reported through 2025. It continued quarterly dividend distributions amid market volatility, posting year-to-date returns of approximately 17.36% and one-year returns of 10.24% as of late 2025, supported by holdings in strong performers like AbbVie.